Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05811312 · ClinicalTrials.gov registry record

Brain Connectivity Changes With Spinal Cord Stimulation and Treatment of Chronic Pain: A Resting State NIRS/EEG Study

A clinical trial of Neuropathic Pain, sponsored by VA Office of Research and Development.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT05811312: Recruiting study of Neuropathic Pain, sponsored by VA Office of Research and Development.

NCT05811312 is a study of Neuropathic Pain that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 40 participants, below the 100-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05811312, a study of Neuropathic Pain, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

This study aims to assess how use of spinal cord stimulation for the treatment of chronic pain impacts brain structure and function. The investigators will use a non-invasive neuroimaging technique called resting state Near Infrared Spectroscopy and Electroencephalography (rs-fNIRS/EEG). The investigators will enroll Veterans who are currently receiving care at the Medical Center and who are either long term users of SCS for the treatment of their chronic pain or being evaluated for use of SCS to treat their pain.

Primary Outcome

Resting state functional connectivity will be evaluated with fNIRS and EEG. The investigators will model "response to SCS" with changes in resting state functional connectivity between five bilateral cortical regions. These regions are the medial prefrontal cortex (mPF), dorsolateral prefrontal cortex (DLPFC), primary motor cortex (M1), primary sensory cortex (S1), and posterior parietal cortex (PPC). Brain connectivity will be evaluated with fNIRS and EEG. Prefrontal medial cortex and posterior

Conditions Studied

Study Locations (1)

Ohio

  • Louis Stokes VA Medical Center, Cleveland, OH - Cleveland

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-07-01
Est. Completion 2026-06-30
VA Office of Research and Development

1,668 total trials

What NCT05811312 shows while recruiting

NCT05811312 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 100-participant average among 35 other Neuropathic Pain trials with a reported enrollment target (60% lower).

The record links to 1 condition, with Neuropathic Pain appearing as the primary indexed condition, and to 0 interventions.

NCT05811312 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT05811312 about?

NCT05811312 is a clinical study titled "Brain Connectivity Changes With Spinal Cord Stimulation and Treatment of Chronic Pain: A Resting State NIRS/EEG Study". This study aims to assess how use of spinal cord stimulation for the treatment of chronic pain impacts brain structure and function. The investigators will use a non-invasive neuroimaging technique called resting state Near Infrared Spectroscopy and Electroencephalography (rs-fNIRS/EEG). The investi...

What is the current status of trial NCT05811312?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2023-07-01. Estimated completion is 2026-06-30.

What conditions does trial NCT05811312 study?

This clinical trial studies the following conditions: Neuropathic Pain.

Who is sponsoring clinical trial NCT05811312?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05811312 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Neuropathic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05811312's enrollment target sits among peer trials

40 17th of 35 higher than 19 of 35 other Neuropathic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Neuropathic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05811312, the US trial registry maintained by the National Library of Medicine. NCT05811312 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.